Publication | Closed Access

Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cells

OncologyMedicineColorectal CancerCancer GenomicsVitamin DStemness-related GenesCell BiologyTumor SuppressorStem CellsRadiation OncologyTumor MicroenvironmentTumor Biology5-Fu Refractory CellsHealth Sciences